Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke

Hiwasa, T; Wang, H; Goto, KI; Mine, S; Machida, T; Kobayashi, E; Yoshida, Y; Adachi, A; Matsutani, T; Sata, M; Yamagishi, K; Iso, H; Sawada, N; Tsugane, S; Kunimatsu, M; Kamitsukasa, I; Mori, M; Sugimoto, K; Uzawa, A; Muto, M; Kuwabara, S; Kobayashi, Y; Ohno, M; Nishi, E; Hattori, A; Yamamoto, M; Maezawa, Y; Kobayashi, K; Ishibashi, R; Takemoto, M; Yokote, K; Takizawa, H; Kishimoto, T; Matsushita, K; Kobayashi, S; Nomura, F; Arasawa, T; Kagaya, A; Maruyama, T; Matsubara, H; Tomiita, M; Hamanaka, S; Imai, Y; Nakagawa, T; Kato, N; Terada, J; Matsumura, T; Katsumata, Y; Naito, A; Tanabe, N; Sakao, S; Tatsumi, K; Ito, M; Shiratori, F; Sumazaki, M; Yajima, S; Shimada, H; Shirouzu, M; Yokoyama, S; Kudo, T; Doi, H; Iwase, K; Ashino, H; Li, SY; Kubota, M; Tomiyoshi, G; Shinmen, N; Nakamura, R; Kuroda, H; Iwadate, Y

Hiwasa, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Neurol Surg, Chiba 2608670, Japan.; Hiwasa, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Biochem & Genet, Chiba 2608670, Japan.

BMC MEDICINE, 2021; 19 (1):

Abstract

Background Acute ischemic stroke (AIS) is a serious cause of mortality and disability. AIS is a serious cause of mortality and disability. Early diagn......

Full Text Link